Title
Biolocity Announces 2026-2027 Awardees Advancing the Future of Cancer Care, Surgery, Diagnostics, and Healthcare Delivery
ID
Jun 25, 2026
| By Kelly Petty
News Image
Image Caption
Judges from industry, business, medicine, and academia listen to teams describe their projects during Biolocity Pitch Day in May.
Widgets
CELORB Team Members: Shuichi Takayama, PhD; Yesim Gokmen-Polar, PhD; Nathan Ocampo
CELORB is developing advanced human tissue models that enable cancer drug developers to evaluate both therapeutic effectiveness and lung toxicity on a single platform. By combining patient-derived cancer and immune cells with engineered scaffolds, the technology delivers faster, more predictive preclinical insights than traditional rodent or organoid models.
CELORB is developing advanced human tissue models that enable cancer drug developers to evaluate both therapeutic effectiveness and lung toxicity on a single platform. By combining patient-derived cancer and immune cells with engineered scaffolds, the technology delivers faster, more predictive preclinical insights than traditional rodent or organoid models.
OrganoAb Biosciences Team Members: Ankur Singh, PhD; Andrés J. García, PhD; Tracey Mullen, MBA; Jean Koff, MD, MS
OrganoAb Biosciences is developing a next-generation antibody discovery platform designed to unlock previously inaccessible therapeutic targets. By enabling the generation of human antibodies against difficult-to-target proteins, the platform has the potential to expand treatment pipelines across cancer and other complex diseases while reducing early-stage discovery risk.
OrganoAb Biosciences is developing a next-generation antibody discovery platform designed to unlock previously inaccessible therapeutic targets. By enabling the generation of human antibodies against difficult-to-target proteins, the platform has the potential to expand treatment pipelines across cancer and other complex diseases while reducing early-stage discovery risk.
Protected Surgical Suction Tip Principal Investigator: Orr Shauly, MD
The Protected Surgical Suction Tip is a dual-state surgical device that combines powerful suction with atraumatic tissue protection in a single instrument. Surgeons can instantly switch between open high-flow mode and a mesh-protected mode, reducing clogs, tissue injury, and instrument exchanges while improving efficiency and patient safety across surgical specialties.
The Protected Surgical Suction Tip is a dual-state surgical device that combines powerful suction with atraumatic tissue protection in a single instrument. Surgeons can instantly switch between open high-flow mode and a mesh-protected mode, reducing clogs, tissue injury, and instrument exchanges while improving efficiency and patient safety across surgical specialties.
AnchorDoc Team Members: Yue Chen, PhD; Samuel Wilcox; Chang Zhou, PhD; John Moon, MD; Hanssen Li, MD; Nicholas Lima, MD
AnchorDoc is a medical device designed to securely stabilize drainage catheters during movement and in wet conditions where existing solutions often fail. The technology aims to reduce complications, avoid repeat procedures, and improve patient safety and comfort in both hospital and home-care settings.
AnchorDoc is a medical device designed to securely stabilize drainage catheters during movement and in wet conditions where existing solutions often fail. The technology aims to reduce complications, avoid repeat procedures, and improve patient safety and comfort in both hospital and home-care settings.
Blood Rheology Solutions Team Members: Vivien Sheehan, MD, PhD; Wilbur A. Lam, MD, PhD; Ashwin Patel, MBBS, PhD, MPH, Megan Merritt-Garza, MS; Srija Ponna, MS; Jedidah Titus, BS
Blood Rheology Solutions is advancing a precision medicine approach for sickle cell disease through clinically validated diagnostic technologies that identify the underlying drivers of patient complications and match patients with the most appropriate therapies. The platform has the potential to improve clinical trial success, enable earlier intervention, and support proactive disease management before severe complications occur.
Blood Rheology Solutions is advancing a precision medicine approach for sickle cell disease through clinically validated diagnostic technologies that identify the underlying drivers of patient complications and match patients with the most appropriate therapies. The platform has the potential to improve clinical trial success, enable earlier intervention, and support proactive disease management before severe complications occur.
EsoBASE™ Team Members: Anand S. Jain, MD
and Ajay Bhave
EsoBASE™ is a single-use device designed to reduce dangerous complications during stomach and esophageal procedures without requiring general anesthesia. By redirecting stomach contents away from the airway, the technology has the potential to make high-risk endoscopic procedures safer, faster, and more accessible across care settings.
EsoBASE™ is a single-use device designed to reduce dangerous complications during stomach and esophageal procedures without requiring general anesthesia. By redirecting stomach contents away from the airway, the technology has the potential to make high-risk endoscopic procedures safer, faster, and more accessible across care settings.
NeuroBot Team Members: Kimberly Hoang, MD; Azadeh Ansari, PhD; Emmett Z. Freeman
NeuroBot is developing tiny, steerable microrobots designed to help surgeons safely access and treat hard-to-reach brain tumors. The technology aims to make biopsies and targeted therapies more precise, less invasive, and more repeatable, potentially improving diagnostic accuracy, treatment options, and patient outcomes.
NeuroBot is developing tiny, steerable microrobots designed to help surgeons safely access and treat hard-to-reach brain tumors. The technology aims to make biopsies and targeted therapies more precise, less invasive, and more repeatable, potentially improving diagnostic accuracy, treatment options, and patient outcomes.
WorkforceIQ Team Members: Omid Razmpour, Ph.D., MBA, RN; Sokol Tushe, PhD; Donald Lee, PhD; Tyki Wada, MBA
WorkforceIQ is developing a data-driven platform that helps healthcare leaders identify early warning signs of nursing burnout and workforce instability before staff attrition occurs. Grounded in peer-reviewed methods for dynamic risk forecasting, the platform translates hospital operational data into actionable insights — strengthening workforce retention, supporting nurses, and improving continuity of patient care.
WorkforceIQ is developing a data-driven platform that helps healthcare leaders identify early warning signs of nursing burnout and workforce instability before staff attrition occurs. Grounded in peer-reviewed methods for dynamic risk forecasting, the platform translates hospital operational data into actionable insights — strengthening workforce retention, supporting nurses, and improving continuity of patient care.